{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:29:47Z","timestamp":1786984187721,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ajoc.2025.102475","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T21:25:31Z","timestamp":1762464331000},"page":"102475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Efficacy of faricimab for recalcitrant multifactorial cystoid macular edema"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5647-7954","authenticated-orcid":false,"given":"Justin","family":"Hanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6991-6867","authenticated-orcid":false,"given":"Marcus","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-9191","authenticated-orcid":false,"given":"Edmund","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajoc.2025.102475_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/09273948.2019.1652330","article-title":"Macular edema after successful pars plana vitrectomy for rhegmatogenous retinal detachment: factors affecting edema development and considerations for treatment","volume":"29","author":"Chatziralli","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102475_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00417-014-2655-x","article-title":"Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane","volume":"253","author":"Frisina","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102475_bib3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3928\/1542-8877-19970401-06","article-title":"Role of the vitreous and macular edema in branch retinal vein occlusion","volume":"28","author":"Takahashi","year":"1997","journal-title":"Ophthalmic Surg Laser"},{"issue":"8","key":"10.1016\/j.ajoc.2025.102475_bib4","article-title":"Vitreoretinal interface abnormalities in patients with retinal vein occlusion in a tertiary referral center","volume":"16","author":"Chatziralli","year":"2024","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102475_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.oret.2017.10.016","article-title":"The pattern of recurrence in diabetic macular edema treated by dexamethasone implant: the PREDIAMEX study","volume":"2","author":"Bellocq","year":"2018","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102475_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00417-019-04495-9","article-title":"Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy","volume":"258","author":"Suzuki","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2025.102475_bib7","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/IAE.0000000000000892","article-title":"Recalcitrant cystoid MACULAR edema after pars plana vitrectomy","volume":"36","author":"Alam","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.ajoc.2025.102475_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000004132","article-title":"Suprachoroidal triamcinolone acetonide for refractory postoperative cystoid macular edema","author":"Momenaei","year":"2024","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102475_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12886-023-02808-5","article-title":"Suprachoroidal triamcinolone acetonide for the treatment of macular edema associated with retinal vein occlusion: a pilot study","volume":"23","author":"Ali","year":"2023","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2025.102475_bib10","article-title":"BALATON and COMINO: phase III randomized clinical trials of faricimab for retinal vein occlusion: study design and rationale","volume":"3","author":"Hattenbach","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"12","key":"10.1016\/j.ajoc.2025.102475_bib11","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1097\/IAE.0000000000000238","article-title":"Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab","volume":"34","author":"Eadie","year":"2014","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ajoc.2025.102475_bib12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ophtha.2020.01.006","article-title":"Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis: phase 3 randomized trial","volume":"127","author":"Yeh","year":"2020","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102475_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12886-023-02808-5","article-title":"Suprachoroidal triamcinolone acetonide for the treatment of macular edema associated with retinal vein occlusion: a pilot study","volume":"23","author":"Ali","year":"2023","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2025.102475_bib14","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","article-title":"Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data","volume":"35","author":"Joussen","year":"2021","journal-title":"Eye (Lond)"},{"issue":"18","key":"10.1016\/j.ajoc.2025.102475_bib15","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1038\/s41433-024-03364-y","article-title":"Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema","volume":"38","author":"Borchert","year":"2024","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102475_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.oret.2017.07.013","article-title":"Suprachoroidal triamcinolone acetonide for retinal vein occlusion: results of the tanzanite study","volume":"2","author":"Campochiaro","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ajoc.2025.102475_bib17","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2147\/OPTH.S361636","article-title":"Modified microneedle for suprachoroidal injection of triamcinolone acetonide combined with intravitreal injection of ranibizumab in branch retinal vein occlusion patients","volume":"16","author":"Nawar","year":"2022","journal-title":"Clin Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625002282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625002282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:45:50Z","timestamp":1773312350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993625002282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":17,"alternative-id":["S2451993625002282"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102475","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of faricimab for recalcitrant multifactorial cystoid macular edema","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102475"}}